(Q44174170)

30 November 2017

Detection of circulating tumor cells in different stages of prostate cancer (English)

1 reference

30 November 2017

1 reference

3

1 reference

30 November 2017

4

Michael Souvatzoglou

1 reference

30 November 2017

Mark Thalgott

1

1 reference

30 November 2017

Brigitte Rack

2

1 reference

30 November 2017

Matthias Eiber

5

1 reference

30 November 2017

Veronika Kreß

6

1 reference

30 November 2017

Matthias M Heck

7

1 reference

30 November 2017

Ulrich Andergassen

8

1 reference

30 November 2017

Roman Nawroth

9

1 reference

30 November 2017

Jürgen E Gschwend

10

1 reference

30 November 2017

Margitta Retz

11

1 reference

30 November 2017

29 January 2013

1 reference

Journal of Cancer Research and Clinical Oncology

30 November 2017

1 reference

30 November 2017

139

1 reference

30 November 2017

5

1 reference

30 November 2017

755-763

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-013-1377-5

30 November 2017

0 references

cites work

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Circulating tumor cells in patients with castration-resistant prostate cancer baseline values and correlation with prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1377-5

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

21 January 2018

1 reference

12 December 2020

Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status

1 reference

12 December 2020

Circulating tumor cells predict survival in patients with metastatic prostate cancer

1 reference

12 December 2020

Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

1 reference

12 December 2020

Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapy

1 reference

12 December 2020

Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance

1 reference

12 December 2020

Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer

1 reference

12 December 2020

Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer

1 reference

12 December 2020

A new parameter for measuring metastatic bone involvement by prostate cancer: the Bone Scan Index.

1 reference

12 December 2020

International Validation of a Preoperative Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy

1 reference

12 December 2020

Prostate-specific antigen and other serum markers: current concepts from the World Health Organization Second International Consultation on Prostate Cancer

1 reference

12 December 2020

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

1 reference

12 December 2020

10.1007/S00432-013-1377-5

Identifiers

DOI

1 reference

30 November 2017

1 reference